X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 60 filers reported holding X4 PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $352,989 | -43.8% | 323,843 | 0.0% | 0.00% | – |
| Q2 2023 | $628,255 | +1603.7% | 323,843 | +664.0% | 0.00% | – |
| Q1 2023 | $36,876 | -12.4% | 42,386 | 0.0% | 0.00% | – |
| Q4 2022 | $42,089 | -42.3% | 42,386 | 0.0% | 0.00% | – |
| Q3 2022 | $73,000 | -79.7% | 42,386 | +1.7% | 0.00% | – |
| Q1 2021 | $359,000 | +34.0% | 41,673 | 0.0% | 0.00% | – |
| Q4 2020 | $268,000 | +3.1% | 41,673 | +8.9% | 0.00% | – |
| Q3 2020 | $260,000 | -32.5% | 38,269 | -7.2% | 0.00% | – |
| Q2 2020 | $385,000 | -2.3% | 41,233 | +4.8% | 0.00% | – |
| Q1 2020 | $394,000 | +16.9% | 39,328 | +25.1% | 0.00% | – |
| Q4 2019 | $337,000 | -15.8% | 31,445 | 0.0% | 0.00% | – |
| Q3 2019 | $400,000 | +26.2% | 31,445 | +49.2% | 0.00% | – |
| Q2 2019 | $317,000 | – | 21,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |